Showing results (481-490 of 687) with videos related to

Sort By:
Pageof 69
Cancer Research|August 22, 2015
CD38-Expressing Myeloid-Derived Suppressor Cells Promote Tumor Growth in a Murine Model of Esophageal CancerTatiana A Karakasheva, Todd J Waldron, Evgeniy Eruslanov, et al.
Differentiation; Research in Biological Diversity|June 9, 2006
Heparanase regulates esophageal keratinocyte differentiation through nuclear translocation and heparan sulfate cleavageMasahiko Kobayashi, Yoshio Naomoto, Tetsuji Nobuhisa, et al.
Contemporary Clinical Trials|March 13, 2016
A randomized phase II dose-response exercise trial among colon cancer survivors: Purpose, study design, methods, and recruitment resultsJustin C Brown, Andrea B Troxel, Bonnie Ky, et al.
Clinical Colorectal Cancer|July 4, 2017
Dose-response Effects of Aerobic Exercise Among Colon Cancer Survivors: A Randomized Phase II TrialJustin C Brown, Andrea B Troxel, Bonnie Ky, et al.
Endocrine-Related Cancer|October 12, 2017
Dose-response effects of exercise on insulin among colon cancer survivorsJustin C Brown, Michael R Rickels, Andrea B Troxel, et al.
British Journal of Cancer|September 22, 2017
Dose-response effects of aerobic exercise on body composition among colon cancer survivors: a randomised controlled trialJustin C Brown, Babette S Zemel, Andrea B Troxel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 15, 2023
Epidemiology of Gastric Malignancies 2000-2018 According to Histology: A Population-Based Analysis of Incidence and Temporal TrendsSheila D Rustgi, Meg McKinley, Brandon McBay, et al.
Surgery|January 1, 1997
Analysis of K-ras oncogene mutations in chronic pancreatitis with ductal hyperplasiaJ A Rivera, C J Rall, F Graeme-Cook, et al.
Nature Communications|March 23, 2019
Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinomaShuo Qie, Akihiro Yoshida, Stuart Parnham, et al.
Annals of Surgery|November 14, 1997
Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreasK Z'graggen, J A Rivera, C C Compton, et al.
Pageof 69